Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the Asia-Pacific Drugs of Abuse Testing Devices Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Drugs of abuse testing are an advanced technique for detecting an illegal or prescribed substance in the sample such as hair, blood, urine, saliva, or sweat. This process includes the screening test followed by the identification of drugs present in the sample. This test can be used for medical screening, forensic data, pain medication, and athletics testing. Overall, the drugs of abuse testing focus on the identification of drugs or combination of drugs a person is receiving for proper treatment. Sample collection devices, an expansive test menu, compact bench-top clinical analyzers, and data management options are some of the major devices of drugs of abuse testing.
A growing number of people consuming alcohol and illicit drugs such as marijuana and cocaine is predominantly fueling the growth of Asia Pacific drugs of abuse testing market. According to the report published by India Today in June 2019, the surveys in India in 2018 and Nigeria in 2017 have offered great insights into drug consumption due to being such vast demographics for their region. India accounts for 30 percent of the population in Asia alone. The report reveals that of the 271 million people that used any drug, 35 million (nearly 13 percent) suffer from a drug use disorder.
On the other hand, lack of awareness regarding the drug testing across certain countries of Asia Pacific is expected to restrict the growth of the drug abuse testing market
Key Developments:
• In January 2019, two new urine drug screens received approval for quick In-Office Testing. The iCUP Rx Drug Screen, introduced by Alere (Waltham, Massachusetts), delivers drug levels for five of the most commonly abused opioid-derived drugs. The second new test, the Sefria Drug Screening Kit, is the first and only available in-office product to enable physicians to monitor for the presence of fentanyl; the Sefria kit is available from Immunalysis Corporation, a division of Alere.
• In January 2020, Siemens Healthineers is now distributing the ARK™ Fentanyl Assay, providing laboratories with a greater window to screen for fentanyl to more effectively triage patients who have been exposed to the dangerous opioid.
• In April 2018, Ortho Clinical Diagnostics, Raritan, NJ, has announced an international distribution and co-promotion agreement with Thermo Fisher Scientific, Waltham, Mass, to offer 14 assays for use in monitoring therapeutic drugs, immunosuppressive drugs, and drugs of abuse.
• In February 2017, the Bartholomew County Sheriff’s Department in Indiana received approval to buy a TruNarc Handheld Narcotics Analyzer. The device has the capability to test for 370 illicit substances without requiring police to open any packaging that may be around the suspected substance.
Geographically, this report split Asia-Pacific into several key Regions, with sales (Units), Revenue (Million USD), market share and growth rate of Drugs of Abuse Testing Devices for these regions, from 2014 to 2025 (forecast), including
⤍ China
⤍ Japan
⤍ South Korea
⤍ Taiwan
⤍ India
⤍ Southeast Asia
⤍ Australia
Asia-Pacific Drugs of Abuse Testing Devices market competition by top manufacturers/players, with Drugs of Abuse Testing Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
⤍ F. Hoffmann La-Roche
⤍ Siemens Healthineers
⤍ Thermo Fisher Scientific
⤍ Alere
⤍ Shimadzu
⤍ Laboratory Corporation of America Holdings
⤍ Dragerwerk
⤍ Express Diagnostics International
On the basis of product, this report displays the sales volume (Units), Revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
⤍ Saliva Testing
⤍ Breath Testing
⤍ Urine Testing
⤍ Blood Testing
⤍ Hair & Sweat Testing
⤍ Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (Units), market share and growth rate of Drugs of Abuse Testing Devices for each application, including
⤍ Hospitals
⤍ Diagnostics Laboratories
⤍ On-the-spot Testing
⤍ Forensic Laboratories
⤍ Other
** NOTE: If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Asia-Pacific Drugs of Abuse Testing Devices Market Report 2019
1 Drugs of Abuse Testing Devices Overview
1.1 Product Overview and Scope of Drugs of Abuse Testing Devices
1.2 Classification of Drugs of Abuse Testing Devices by Product Category
1.2.1 Asia-Pacific Drugs of Abuse Testing Devices Market Size (Sales) Comparison by Types (2014-2025)
1.2.2 Asia-Pacific Drugs of Abuse Testing Devices Market Size (Sales) Market Share by Type (Product Category) in 2018
1.2.3 Saliva Testing
1.2.4 Breath Testing
1.2.5 Urine Testing
1.2.6 Blood Testing
1.2.7 Hair & Sweat Testing
1.2.8 Otehr
1.3 Asia-Pacific Drugs of Abuse Testing Devices Market by Application/End Users
1.3.1 Asia-Pacific Drugs of Abuse Testing Devices Sales (Volume) and Market Share Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Diagnostics Laboratories
1.3.4 On-the-spot Testing
1.3.5 Forensic Laboratories
1.3.6 Other
1.4 Asia-Pacific Drugs of Abuse Testing Devices Market by Region
1.4.1 Asia-Pacific Drugs of Abuse Testing Devices Market Size (Value) Comparison by Region (2014-2025)
1.4.2 China Status and Prospect (2014-2025)
1.4.3 Japan Status and Prospect (2014-2025)
1.4.4 South Korea Status and Prospect (2014-2025)
1.4.5 Taiwan Status and Prospect (2014-2025)
1.4.6 India Status and Prospect (2014-2025)
1.4.7 Southeast Asia Status and Prospect (2014-2025)
1.4.8 Australia Status and Prospect (2014-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Drugs of Abuse Testing Devices (2014-2025)
1.5.1 Asia-Pacific Drugs of Abuse Testing Devices Sales and Growth Rate (2014-2025)
1.5.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2025)
2 Asia-Pacific Drugs of Abuse Testing Devices Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific Drugs of Abuse Testing Devices Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Drugs of Abuse Testing Devices Sales Volume and Market Share of Key Players/Suppliers (2014-2019)
2.1.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue and Share by Players/Suppliers (2014-2019)
2.2 Asia-Pacific Drugs of Abuse Testing Devices (Volume and Value) by Type
2.2.1 Asia-Pacific Drugs of Abuse Testing Devices Sales and Market Share by Type (2014-2019)
2.2.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue and Market Share by Type (2014-2019)
2.3 Asia-Pacific Drugs of Abuse Testing Devices (Volume) by Application
2.4 Asia-Pacific Drugs of Abuse Testing Devices (Volume and Value) by Region
2.4.1 Asia-Pacific Drugs of Abuse Testing Devices Sales and Market Share by Region (2014-2019)
2.4.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue and Market Share by Region (2014-2019)
3 China Drugs of Abuse Testing Devices (Volume, Value and Sales Price)
3.1 China Drugs of Abuse Testing Devices Sales and Value (2014-2019)
3.1.1 China Drugs of Abuse Testing Devices Sales Volume and Growth Rate (2014-2019)
3.1.2 China Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2019)
3.1.3 China Drugs of Abuse Testing Devices Sales Price Trend (2014-2019)
3.2 China Drugs of Abuse Testing Devices Sales Volume and Market Share by Type
3.3 China Drugs of Abuse Testing Devices Sales Volume and Market Share by Application
4 Japan Drugs of Abuse Testing Devices (Volume, Value and Sales Price)
4.1 Japan Drugs of Abuse Testing Devices Sales and Value (2014-2019)
4.1.1 Japan Drugs of Abuse Testing Devices Sales Volume and Growth Rate (2014-2019)
4.1.2 Japan Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2019)
4.1.3 Japan Drugs of Abuse Testing Devices Sales Price Trend (2014-2019)
4.2 Japan Drugs of Abuse Testing Devices Sales Volume and Market Share by Type
4.3 Japan Drugs of Abuse Testing Devices Sales Volume and Market Share by Application
5 South Korea Drugs of Abuse Testing Devices (Volume, Value and Sales Price)
5.1 South Korea Drugs of Abuse Testing Devices Sales and Value (2014-2019)
5.1.1 South Korea Drugs of Abuse Testing Devices Sales Volume and Growth Rate (2014-2019)
5.1.2 South Korea Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2019)
5.1.3 South Korea Drugs of Abuse Testing Devices Sales Price Trend (2014-2019)
5.2 South Korea Drugs of Abuse Testing Devices Sales Volume and Market Share by Type
5.3 South Korea Drugs of Abuse Testing Devices Sales Volume and Market Share by Application
6 Taiwan Drugs of Abuse Testing Devices (Volume, Value and Sales Price)
6.1 Taiwan Drugs of Abuse Testing Devices Sales and Value (2014-2019)
6.1.1 Taiwan Drugs of Abuse Testing Devices Sales Volume and Growth Rate (2014-2019)
6.1.2 Taiwan Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2019)
6.1.3 Taiwan Drugs of Abuse Testing Devices Sales Price Trend (2014-2019)
6.2 Taiwan Drugs of Abuse Testing Devices Sales Volume and Market Share by Type
6.3 Taiwan Drugs of Abuse Testing Devices Sales Volume and Market Share by Application
7 India Drugs of Abuse Testing Devices (Volume, Value and Sales Price)
7.1 India Drugs of Abuse Testing Devices Sales and Value (2014-2019)
7.1.1 India Drugs of Abuse Testing Devices Sales Volume and Growth Rate (2014-2019)
7.1.2 India Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2019)
7.1.3 India Drugs of Abuse Testing Devices Sales Price Trend (2014-2019)
7.2 India Drugs of Abuse Testing Devices Sales Volume and Market Share by Type
7.3 India Drugs of Abuse Testing Devices Sales Volume and Market Share by Application
8 Southeast Asia Drugs of Abuse Testing Devices (Volume, Value and Sales Price)
8.1 Southeast Asia Drugs of Abuse Testing Devices Sales and Value (2014-2019)
8.1.1 Southeast Asia Drugs of Abuse Testing Devices Sales Volume and Growth Rate (2014-2019)
8.1.2 Southeast Asia Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2019)
8.1.3 Southeast Asia Drugs of Abuse Testing Devices Sales Price Trend (2014-2019)
8.2 Southeast Asia Drugs of Abuse Testing Devices Sales Volume and Market Share by Type
8.3 Southeast Asia Drugs of Abuse Testing Devices Sales Volume and Market Share by Application
9 Australia Drugs of Abuse Testing Devices (Volume, Value and Sales Price)
9.1 Australia Drugs of Abuse Testing Devices Sales and Value (2014-2019)
9.1.1 Australia Drugs of Abuse Testing Devices Sales Volume and Growth Rate (2014-2019)
9.1.2 Australia Drugs of Abuse Testing Devices Revenue and Growth Rate (2014-2019)
9.1.3 Australia Drugs of Abuse Testing Devices Sales Price Trend (2014-2019)
9.2 Australia Drugs of Abuse Testing Devices Sales Volume and Market Share by Type
9.3 Australia Drugs of Abuse Testing Devices Sales Volume and Market Share by Application
10 Asia-Pacific Drugs of Abuse Testing Devices Players/Suppliers Profiles and Sales Data
10.1 F. Hoffmann La-Roche
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 F. Hoffmann La-Roche Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.1.4 Main Business/Business Overview
10.2 Siemens Healthineers
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Siemens Healthineers Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.2.4 Main Business/Business Overview
10.3 Thermo Fisher Scientific
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Thermo Fisher Scientific Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.3.4 Main Business/Business Overview
10.4 Alere
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Alere Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.4.4 Main Business/Business Overview
10.5 Shimadzu
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Shimadzu Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.5.4 Main Business/Business Overview
10.6 Laboratory Corporation of America Holdings
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Laboratory Corporation of America Holdings Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.6.4 Main Business/Business Overview
10.7 Dragerwerk
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Dragerwerk Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.7.4 Main Business/Business Overview
10.8 Express Diagnostics International
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Drugs of Abuse Testing Devices Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Express Diagnostics International Drugs of Abuse Testing Devices Sales, Revenue, Price and Gross Margin (2014-2019)
10.8.4 Main Business/Business Overview
11 Drugs of Abuse Testing Devices Manufacturing Cost Analysis
11.1 Drugs of Abuse Testing Devices Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs of Abuse Testing Devices
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drugs of Abuse Testing Devices Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs of Abuse Testing Devices Major Manufacturers in 2018
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change
15 Asia-Pacific Drugs of Abuse Testing Devices Market Forecast (2019-2025)
15.1 Asia-Pacific Drugs of Abuse Testing Devices Sales Volume, Revenue and Price Forecast (2019-2025)
15.1.1 Asia-Pacific Drugs of Abuse Testing Devices Sales Volume and Growth Rate Forecast (2019-2025)
15.1.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue and Growth Rate Forecast (2019-2025)
15.1.3 Asia-Pacific Drugs of Abuse Testing Devices Price and Trend Forecast (2019-2025)
15.2 Asia-Pacific Drugs of Abuse Testing Devices Sales Volume, Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.1 Asia-Pacific Drugs of Abuse Testing Devices Sales Volume and Growth Rate Forecast by Region (2019-2025)
15.2.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue and Growth Rate Forecast by Region (2019-2025)
15.2.3 China Drugs of Abuse Testing Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.4 Japan Drugs of Abuse Testing Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.5 South Korea Drugs of Abuse Testing Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.6 Taiwan Drugs of Abuse Testing Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.7 India Drugs of Abuse Testing Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.8 Southeast Asia Drugs of Abuse Testing Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.2.9 Australia Drugs of Abuse Testing Devices Sales, Revenue and Growth Rate Forecast (2019-2025)
15.3 Asia-Pacific Drugs of Abuse Testing Devices Sales, Revenue and Price Forecast by Type (2019-2025)
15.3.1 Asia-Pacific Drugs of Abuse Testing Devices Sales Forecast by Type (2019-2025)
15.3.2 Asia-Pacific Drugs of Abuse Testing Devices Revenue Forecast by Type (2019-2025)
15.3.3 Asia-Pacific Drugs of Abuse Testing Devices Price Forecast by Type (2019-2025)
15.4 Asia-Pacific Drugs of Abuse Testing Devices Sales Forecast by Application (2019-2025)
16 Research Findings and Conclusion
17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer
